In vitro cytotoxicity MTT assay in Vero, HepG2 and MCF -7 cell lines study of Marine Yeast.

dc.contributor.authorSenthilraja, P
dc.contributor.authorKathiresan, K
dc.date.accessioned2015-07-06T09:52:23Z
dc.date.available2015-07-06T09:52:23Z
dc.date.issued2015-03
dc.description.abstractMarine yeasts isolated from coastal mangrove ecosystem namely Candida albicans, Kuraishia capsulate and Sacchromyces cerevisae were screened for the cytotoxicity against a non-transformed Vero (African green monkey kidney normal cell line) and two cancer cell lines human breast carcinoma cells (HepG2), human breast carcinoma cells (MCF -7) in different concentrations (1000 to 1.953 μg/ml). Lower doses enhanced the viability of the cultured cells, MTT assay .higher doses decreased viability of the cells by 50% or more. MTT assay was used to measure the cell proliferation and survival. Amongst three yeast strains, Sacchromyces cerevisae showed more than 80% cell viability in Vero cell lines and were studied for further cytotoxicity against HepG2, MCF -7 cell lines respectively.en_US
dc.identifier.citationSenthilraja P, Kathiresan K. In vitro cytotoxicity MTT assay in Vero, HepG2 and MCF -7 cell lines study of Marine Yeast. Journal of Applied Pharmaceutical Science. 2015 Mar; 5(3): 80-84.en_US
dc.identifier.issn2231-3354
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/159142
dc.language.isoenen_US
dc.source.urihttps://www.japsonline.com/counter.php?aid=1457en_US
dc.subjectYeasten_US
dc.subjectcanceren_US
dc.subjectMTT assayen_US
dc.subjectCell cultureen_US
dc.subjectVeroen_US
dc.subjectHepG2en_US
dc.subjectMCF-7en_US
dc.titleIn vitro cytotoxicity MTT assay in Vero, HepG2 and MCF -7 cell lines study of Marine Yeast.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
japs2015v5n3p80.pdf
Size:
192.06 KB
Format:
Adobe Portable Document Format
Description:
Research article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: